BeOne Medicines (ONC) Inventory Average (2017 - 2026)

BeOne Medicines (ONC) has 10 years of Inventory Average data on file, last reported at $644.9 million in Q1 2026.

• Quarterly Inventory Average rose 30.33% year-over-year to $644.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $644.9 million (up 30.33% YoY) and the FY2025 annual result came in at $551.6 million, up 21.08% from the prior year.
• Inventory Average grew to $644.9 million in Q1 2026 per ONC's latest filing, from $570.0 million in the prior quarter.
• Across five years, Inventory Average topped out at $644.9 million in Q1 2026 and bottomed at $244.1 million in Q1 2022.
• The 5-year median for Inventory Average is $431.7 million (2024), against an average of $402.9 million.
• The widest annual swing landed in 2022, when Inventory Average jumped 200.9%; it then increased 12.01% in 2025.
• Tracing ONC's Inventory Average over 5 years: stood at $286.6 million in 2022, then climbed by 27.87% to $366.5 million in 2023, then grew by 26.41% to $463.3 million in 2024, then grew by 23.01% to $570.0 million in 2025, then rose by 13.15% to $644.9 million in 2026.
• Per Business Quant, the three latest ONC Inventory Average figures stand at $644.9 million (Q1 2026), $570.0 million (Q4 2025), and $517.3 million (Q3 2025).

Peer Comparison